Načítá se...

One gene to rule them all…and in the darkness bind them

Pharmaceutical inhibition of the Human Epidermal growth factor Receptor 2 (HER2) oncogene has dramatically improved outcomes in HER2-amplified breast cancers. However, monotherapy HER2 inhibitors are not effective. We have recently reported that a co-amplified microRNA within the HER2 amplicon, lead...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cell Oncol
Hlavní autoři: Floros, Konstantinos V., Faber, Anthony C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149778/
https://ncbi.nlm.nih.gov/pubmed/30250918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1465881
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!